Rudolf Valenta Selected Research

Parasitic Diseases (Parasitic Disease)

1/2016	Genetic Variants in CHIA and CHI3L1 Are Associated with the IgE Response to the Ascaris Resistance Marker ABA-1 and the Birch Pollen Allergen Bet v 1.
1/2003	Strategies for the development of safe and effective DNA vaccines for allergy treatment.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Rudolf Valenta Research Topics

Disease

177	Hypersensitivity (Allergy) 03/2024 - 01/2002
46	Asthma (Bronchial Asthma) 11/2023 - 01/2002
45	Seasonal Allergic Rhinitis (Hay Fever) 12/2023 - 01/2002
39	Inflammation (Inflammations) 02/2023 - 09/2003
25	Infections 10/2023 - 05/2009
22	Atopic Dermatitis (Atopic Eczema) 01/2023 - 04/2002
15	Food Hypersensitivity (Food Allergy) 10/2023 - 05/2002
14	COVID-19 04/2023 - 01/2020
11	Anaphylaxis (Anaphylactic Shock) 05/2023 - 03/2004
9	Rhinitis 11/2023 - 05/2015
8	Hepatitis B 05/2022 - 06/2011
6	Allergic Rhinitis 01/2022 - 02/2007
6	Leukemia 01/2022 - 02/2007
5	Communicable Diseases (Infectious Diseases) 01/2020 - 03/2002
4	Skin Diseases (Skin Disease) 01/2023 - 05/2004
4	Milk Hypersensitivity (Milk Allergy) 12/2022 - 06/2009
4	Neoplasms (Cancer) 11/2022 - 01/2003
4	Conjunctivitis 06/2022 - 01/2006
4	Dust Mite Allergy 01/2016 - 01/2008
3	Celiac Disease (Celiac Sprue) 02/2022 - 10/2013
3	Immune System Diseases (Immune Disorders) 01/2021 - 05/2016
3	Respiratory Sounds (Crackle) 01/2021 - 01/2018
3	Respiratory Tract Diseases (Respiratory Tract Disease) 06/2020 - 05/2009
3	Wheat Hypersensitivity (Wheat Allergy) 01/2018 - 01/2009
2	Immediate Hypersensitivity 05/2023 - 03/2002
2	Pneumonia (Pneumonitis) 01/2023 - 05/2018
2	Dermatitis 06/2022 - 09/2013
2	Peanut Hypersensitivity (Peanut Allergy) 01/2021 - 01/2017
2	Nasal Polyps (Nasal Polyp) 01/2021 - 01/2016
2	Eczema 01/2017 - 01/2017
2	Parasitic Diseases (Parasitic Disease) 01/2016 - 01/2003
2	HIV Infections (HIV Infection) 01/2015 - 01/2014
2	Skin Manifestations 01/2014 - 10/2002
2	Virus Diseases (Viral Diseases) 01/2011 - 05/2009
1	Nasal Obstruction 11/2023

Drug/Important Bio-Agent (IBA)

191	AllergensIBA 03/2024 - 01/2002
167	Immunoglobulin E (IgE)IBA 03/2024 - 01/2002
64	VaccinesIBA 10/2023 - 01/2002
40	AntibodiesIBA 10/2023 - 01/2002
38	Peptides (Polypeptides)IBA 12/2023 - 12/2004
37	Immunoglobulin G (IgG)IBA 12/2023 - 08/2002
29	Proteins (Proteins, Gene)FDA Link 10/2023 - 08/2004
24	AntigensIBA 11/2022 - 03/2002
20	EpitopesIBA 10/2022 - 05/2004
10	CytokinesIBA 11/2023 - 05/2004
10	P-2 (P 2)IBA 01/2019 - 01/2002
8	Biomarkers (Surrogate Marker)IBA 06/2022 - 04/2012
6	Immunoglobulin A (IgA)IBA 12/2021 - 11/2005
5	Recombinant Fusion ProteinsIBA 05/2022 - 04/2013
5	Carrier Proteins (Binding Protein)IBA 05/2022 - 05/2009
5	ParvalbuminsIBA 06/2017 - 05/2002
5	AutoantibodiesIBA 09/2008 - 04/2002
4	Pyridinolcarbamate (P23)IBA 01/2022 - 04/2013
4	Membrane Proteins (Integral Membrane Proteins)IBA 09/2020 - 05/2009
4	VenomsIBA 02/2020 - 06/2010
4	B-Lymphocyte Epitopes (B-Cell Epitope)IBA 11/2017 - 05/2005
4	Complementary DNA (cDNA)IBA 01/2014 - 07/2005
4	CalciumIBA 09/2013 - 02/2002
4	AutoantigensIBA 03/2009 - 10/2002
3	Monoclonal AntibodiesIBA 03/2023 - 06/2006
3	Immunoglobulins (Immunoglobulin)IBA 03/2023 - 09/2013
3	ragweed pollenIBA 02/2023 - 01/2018
3	Intercellular Adhesion Molecule-1 (Intercellular Adhesion Molecule 1)IBA 02/2023 - 01/2014
3	Dermatophagoides pteronyssinus antigen p 2IBA 01/2023 - 05/2008
3	CarbohydratesIBA 07/2022 - 04/2011
3	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2022 - 01/2015
3	InterferonsIBA 01/2021 - 01/2018
3	Blocking AntibodiesIBA 06/2017 - 09/2003
3	Antigen-Antibody Complex (Immune Complex)IBA 03/2017 - 03/2009
3	Interleukin-4 (Interleukin 4)IBA 01/2017 - 08/2005
3	Recombinant DNA (Recombinant DNA Research)IBA 02/2016 - 04/2011
3	Combined VaccinesIBA 08/2012 - 08/2002
3	Peptide Hydrolases (Proteases)FDA Link 03/2009 - 05/2006
2	Interleukin-13IBA 11/2023 - 11/2022
2	Lactalbumin (alpha-Lactalbumin)IBA 05/2023 - 06/2010
2	Dendrimers (Dendrons)IBA 01/2023 - 01/2021
2	Small Interfering RNA (siRNA)IBA 01/2023 - 01/2021
2	Glutens (Glutelin)IBA 02/2022 - 12/2015
2	GliadinIBA 02/2022 - 12/2015
2	Omalizumab (Xolair)FDA Link 01/2022 - 03/2017
2	Fibronectins (Fibronectin)IBA 01/2022 - 07/2011
2	anti-IgE antibodiesIBA 01/2022 - 03/2017
2	Indicators and Reagents (Reagents)IBA 01/2020 - 10/2003
2	Wasp Venoms (Venom, Wasp)IBA 01/2018 - 06/2010
2	Dermatophagoides pteronyssinus antigen p 1IBA 01/2017 - 08/2012
2	APTIBA 01/2017 - 02/2016
2	Synthetic Vaccines (Recombinant Vaccines)IBA 02/2016 - 04/2007
2	T-Lymphocyte Epitopes (Epitopes, T Lymphocyte)IBA 02/2016 - 11/2010
2	ProteomeIBA 03/2015 - 01/2015
2	purothioninIBA 01/2014 - 10/2013
2	Aligeron (AS 2)IBA 06/2010 - 08/2004
2	nascent-polypeptide-associated complexIBA 06/2008 - 10/2002
2	Tryptases (Tryptase)IBA 01/2008 - 05/2006
2	DNA VaccinesIBA 09/2006 - 01/2003
1	3-N-butyl-4,5-dihydrophthalide (NBPA)IBA 12/2023
1	Lactoglobulins (beta-Lactoglobulin)FDA Link 05/2023

Therapy/Procedure

63	Immunotherapy 11/2023 - 01/2002
28	Therapeutics 03/2023 - 02/2002
5	Precision Medicine 02/2023 - 08/2017
3	Cell- and Tissue-Based Therapy (Cell Therapy) 03/2024 - 01/2011